Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC), from a single donor, in EGMTM-2 containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) without VEGF, from a single donor, cultured in EGMTM Plus and containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC), from pooled donors, in EGMTM-2 and containing ≥ 500,000 cells
Cryopreserved ampule of Human Human Umbilical Vein Endothelial Cells (HUVEC) from a single donor containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, cultured in EGMTM-2, pre-screened for Angiogenesis and containing ≥ 500,000 cells
-
TechSheet - Umbilical Vein Endothelial Cell SystemsTechnical information sheet for CloneticsTM HUVEC cells
-
Instructions for Use - HUVEC Culturing and Angiogenesis Inhibition Assay using Sartorius Incucyte®Protocol for Angiogenesis assay using HUVEC cells
-
Expanded HUVECs for High-throughput ScreeningHUVECs are a good primary endothelial cell type for many in vitro studies and also for several high-throughput screening applications. Consequently, Lonza offers, HUVEC-XL. These cells are expanded to passage-3 from pooled P1-HUVECs and packaged at 10 million cells per ampoule.
-
Tube Formation Assay with HUVEC
-
HUVEC-Fibroblast Co-Culture - Angiogenesis
-
Tube Formation Assay with Primary HUVECsIn this study, we have optimized this assay using Lonza's Primary HUVECs and EGM™-2 Media
-
HUVEC-Fibroblast Co-Culture – Angiogenesis Inhibition
-
Instructions - HUVEC-XL™ Pooled Cell SystemInstructions for culturing Clonetics™ HIVEC-XL™Pooled Cells
-
Automated Cell Signaling Assays Using Primary HUVECsLonza's Primary HUVECs are an excellent cell type to measure the effects of pharmacologically-important compounds on vial signaling pathways, and they provide increased data relevancy compared to cell lines.
-
Lonza Extends Industry-Standard HUVEC Product LineLonza, the market leader in primary cells, has expanded its human primary cell portfolio with an improved version of Human Umbilical Vein Endothelial Cells (HUVEC) cultured in the absence of additive vascular endothelial growth factor (VEGF).